Cantor Fitzgerald Investment Advisors L.P. lessened its holdings in shares of Ventas, Inc. (NYSE:VTR - Free Report) by 19.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 143,806 shares of the real estate investment trust's stock after selling 35,746 shares during the period. Cantor Fitzgerald Investment Advisors L.P.'s holdings in Ventas were worth $11,128,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. BI Asset Management Fondsmaeglerselskab A S lifted its position in shares of Ventas by 97.7% during the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust's stock worth $2,570,000 after purchasing an additional 18,146 shares during the last quarter. Hudson Bay Capital Management LP acquired a new position in shares of Ventas during the 2nd quarter worth about $17,568,000. Schroder Investment Management Group grew its position in Ventas by 3.6% during the third quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust's stock worth $170,946,000 after buying an additional 85,340 shares in the last quarter. Aberdeen Group plc grew its position in Ventas by 8.3% during the third quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust's stock worth $109,985,000 after buying an additional 120,825 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Ventas by 2.5% during the third quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust's stock worth $5,151,182,000 after buying an additional 1,802,515 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company's stock.
Insider Buying and Selling
In other news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares of the company's stock, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares of the company's stock, valued at approximately $6,184,175. The trade was a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.80% of the company's stock.
Analyst Ratings Changes
VTR has been the subject of several recent research reports. JPMorgan Chase & Co. upped their price target on Ventas from $88.00 to $93.00 and gave the company an "overweight" rating in a report on Friday, March 20th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $93.00 price target on shares of Ventas in a report on Monday, February 9th. UBS Group reaffirmed a "neutral" rating and issued a $85.00 price target on shares of Ventas in a report on Monday, February 9th. Weiss Ratings reaffirmed a "buy (b-)" rating on shares of Ventas in a report on Friday, March 27th. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and set a $100.00 price objective on shares of Ventas in a report on Monday, February 9th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Ventas currently has a consensus rating of "Moderate Buy" and an average target price of $90.47.
Check Out Our Latest Stock Analysis on VTR
Ventas Trading Up 0.0%
Shares of VTR opened at $84.95 on Friday. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $88.36. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. The stock has a 50 day simple moving average of $84.28 and a 200-day simple moving average of $78.49. The stock has a market cap of $40.39 billion, a PE ratio of 157.32, a PEG ratio of 2.10 and a beta of 0.75.
Ventas (NYSE:VTR - Get Free Report) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the company posted $0.81 earnings per share. The company's quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts predict that Ventas, Inc. will post 3.4 EPS for the current fiscal year.
Ventas Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a boost from Ventas's previous quarterly dividend of $0.48. Ventas's payout ratio is currently 385.19%.
About Ventas
(
Free Report)
Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas' business model combines property ownership with active asset management and capital markets activity.
Featured Stories
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report